Inactive Instrument

Highlights Opko Health Inc. Nyse

Equities

OPK

US68375N1037

Real-time Estimate Cboe BZX Other stock markets 07:08:38 02/07/2024 pm IST			5-day change	1st Jan Change
1.23 ^USD	0.00%		0.00%	0.00%

07/05	Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $173.7M, vs. Street Est of $183M	MT
07/05	Opko Health, Inc. Provides Earnings Guidance for the Second Quarter of 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $173.7M, vs. Street Est of $183M	08/05	MT
Opko Health, Inc. Provides Earnings Guidance for the Second Quarter of 2024	08/05	CI
OPKO Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
Entera Bio Announces Robust Pharmacokinetic Data for First-In-Class Oral Glp-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome	20/03	CI
Earnings Flash (OPK) OPKO HEALTH Reports Q4 Revenue $181.9M, vs. Street Est of $177.5M	28/02	MT
OPKO Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02	CI
Drugmakers deepen efforts to tap into booming market for obesity drugs	27/02	RE
Tranche Update on OPKO Health, Inc.'s Equity Buyback Plan announced on January 4, 2024.	10/01	CI
OPKO Health, Inc.'s Equity Buyback announced on January 4, 2024, has closed with 55,145,031 shares, for $50 million.	09/01	CI
OPKO Health, Inc. announces an Equity Buyback for $50 million worth of its shares.	04/01	CI
OPKO Health, Inc. authorizes a Buyback Plan.	03/01	CI
Roche enters obesity drugs race with $2.7 bln Carmot deal	04/12	RE
Roche enters obesity drugs race with $2.7 bln Carmot deal	04/12	RE
OPKO Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11	CI
Earnings Flash (OPK) OPKO HEALTH Posts Q3 Revenue $178.6M, vs. Street Est of $174.8M	07/11	MT
OPKO Health, Inc. Presents Late-Breaking Clinical Data on RAYALDEE Extended-Release Calcifediol	02/11	CI
OPKO Health Subsidiary Lands BARDA Contract	29/23/29	MT
OPKO Health Shares Jump on Better-Than-Expected Q2 Results	04/23/04	MT
Earnings Flash (OPK) OPKO HEALTH Reports Q2 Revenue $265.4M, vs. Street Est of $202M	04/23/04	MT
OPKO Health, Inc. Provides Revenue Guidance for the Third Quarter of 2023	04/23/04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Opko Health Inc. Nyse

Equities

OPK

US68375N1037

Highlights

Filters